Skip to main content

Table 6 Results from multivariate polytomous logistic regression analyses of factors associated with mild (<33% of hepatocytes affected ) and severe (>33% of hepatocytes affected) steatosis in 184 HIV-HCV coinfected patients treated with antiretroviral therapy

From: Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals

 

Mild steatosis AOR (95%CI)

p

Severe steatosis AOR (95%CI)

p

HCV genotype 3

1.76 (0.72-4.30)

0.22

19.51 (4.49-84.73)

<0.0001

HCV RNA (per 1 log10 increase)

1.80 (1.02-3.16)

0.04

14.86 (3.79-58.22)

0.0001

  1. Abbreviations: AOR, adjusted odds ratio; CI, confidence intervals.
Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us